NCAPG and hepatocellular carcinoma: Targeting NCAPG may represent a novel strategy of treating HCC tumors, and the prognostic biomarker potential of NCAPG in predicting early HCC recurrence should also be evaluated in a larger patient cohort to aid the clinical management of HCC.